Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs

Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs Bioorganic & Medicinal Chemistry 26 (2018) 3039–3045 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry journal homepage: www.elsevier.com/locate/bmc Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs a b b b b Rhiannon Beard , Andy Stucki , Muriel Schmitt , Gabrielle Py , Christophe Grundschober , c a,⇑ Antony D. Gee , Edward W. Tate Department of Chemistry, Imperial College London, Exhibition Road, London SW7 2AZ, UK Roche Pharma Research and Early Development, Discovery Neuroscience, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland Division of Imaging Sciences, King’s College London, 4th Floor, Lambeth Wing, St Thomas’ Hospital, SE1 7EH London, UK article i nfo abstract Article history: Oxytocin (OT) is an exciting potential therapeutic agent, but it is highly sensitive to modification and suf- Received 28 January 2018 fers extensive degradation at elevated temperature and in vivo. Here we report studies towards OT ana- Revised 9 March 2018 logs with favorable selectivity, affinity and potency towards the oxytocin receptor (OTR), in addition to Accepted 10 March 2018 improving stability of the peptide by bridging the disulfide region with substituted dibromo-xylene ana- Available online 12 March 2018 logs. We found http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Bioorganic & Medicinal Chemistry Elsevier

Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs

Loading next page...
 
/lp/elsevier/building-bridges-for-highly-selective-potent-and-stable-oxytocin-and-Ys6JQTKeDD
Publisher
Elsevier
Copyright
Copyright © 2018 Elsevier Ltd
ISSN
0968-0896
D.O.I.
10.1016/j.bmc.2018.03.019
Publisher site
See Article on Publisher Site

Abstract

Bioorganic & Medicinal Chemistry 26 (2018) 3039–3045 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry journal homepage: www.elsevier.com/locate/bmc Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs a b b b b Rhiannon Beard , Andy Stucki , Muriel Schmitt , Gabrielle Py , Christophe Grundschober , c a,⇑ Antony D. Gee , Edward W. Tate Department of Chemistry, Imperial College London, Exhibition Road, London SW7 2AZ, UK Roche Pharma Research and Early Development, Discovery Neuroscience, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland Division of Imaging Sciences, King’s College London, 4th Floor, Lambeth Wing, St Thomas’ Hospital, SE1 7EH London, UK article i nfo abstract Article history: Oxytocin (OT) is an exciting potential therapeutic agent, but it is highly sensitive to modification and suf- Received 28 January 2018 fers extensive degradation at elevated temperature and in vivo. Here we report studies towards OT ana- Revised 9 March 2018 logs with favorable selectivity, affinity and potency towards the oxytocin receptor (OTR), in addition to Accepted 10 March 2018 improving stability of the peptide by bridging the disulfide region with substituted dibromo-xylene ana- Available online 12 March 2018 logs. We found

Journal

Bioorganic & Medicinal ChemistryElsevier

Published: Jul 15, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off